Coming Off a Weight-Loss Jab: What the Research Says About Weight Regain, Food Noise and Muscle

4 days ago

6 min read

Kamaldeep Sidhu; Functional Medicine Practitioner and Health Coach. Last updated: 17/10/2026.

A question I'm hearing more and more, usually asked quietly: "If I stop, will it all come back?".

Sometimes it comes from someone who is thinking of stopping. Sometimes it's from someone who has to, because of cost, supply, side effects, or simply because a course has run its length. Either way, the honest answer sits somewhere between ‘don’t worry about it’ and the scarier headlines. So let's look at what the research actually says.

A person stands on some scales to measure their weight.

Does weight come back when you stop a weight-loss jab?

On average, yes, and fairly steadily.

The most comprehensive look so far is a 2026 systematic review in The BMJ from Oxford researchers. It pulled together 37 studies and over 9,000 adults. After people stopped weight-management medication, weight returned at an average of about 0.4 kg a month, and improvements in things like blood pressure and cholesterol tended to fade too [1]. Projected forwards, that points to people drifting back towards their starting weight over roughly a year and a half to two years [1, 8].

The individual trials tell the same story. In SURMOUNT-4, adults who had lost about a fifth of their body weight on tirzepatide were randomly assigned either to carry on or to switch to placebo. Over the following year, the placebo group regained around 14% of their body weight, while those who continued lost a little more [2]. In the STEP 1 extension, people who stopped semaglutide had regained about two-thirds of their weight loss a year later [3].

Does it happen to everyone?

No, and this matters. All of those numbers are averages.

In SURMOUNT-4, nearly half of the people switched to placebo still held on to a loss of at least 10% a year later [2]. The BMJ review followed people for about 32 weeks after stopping, on average, so we know much less about what happens over several years [8]. And no trial can tell you what will happen to you personally.

Why might weight come back faster than after dieting?

The BMJ review found that regain after stopping medication was faster than after stopping diet and exercise programmes, by about 0.3 kg a month, however much weight had been lost [1].

The researchers suggested one possible reason. When a drug quietens your appetite, you don't necessarily practise the day-to-day food habits that help keep weight off [9]. That is a hypothesis, not a proven mechanism.

Here is the finding I found most sobering. Support with diet and activity alongside the medication helped people lose more weight, but it did not appear to slow regain once the drug stopped [8]. So "just keep up the healthy habits" is not a promise the current evidence can make, and I'd rather say that honestly than reassure you with something I can't back up.

What about "food noise"?

"Food noise" is the everyday phrase for persistent, intrusive thoughts about food. It isn't a diagnosis, and it is mostly studied through questionnaires and self-report.

In a survey of 550 people taking semaglutide, participants recalled much more food noise before starting than after [6]. But the survey was retrospective, which means it depends on memory, and it can't separate the effect of the drug from the effect of losing weight. A rare single-person study using brain recordings found that food-noise-related activity quietened on tirzepatide and then began to return after around five months [7]. That is one person, so it's an interesting signal rather than a finding.

I haven't found a good trial that measures food noise after stopping, and I think that is a real gap. It would be unsurprising if appetite and food preoccupation changed once the medication wore off, but "unsurprising" is not the same as "shown".

What about muscle?

In the SURMOUNT-1 body composition substudy, about three-quarters of the weight lost on tirzepatide was fat and about a quarter was lean mass. The proportion was similar in the placebo group [5]. Lean mass isn't the same thing as muscle, as it includes water and organ tissue, so that figure overstates muscle loss.

I'd put it this way: protecting muscle matters, and it matters for reasons that go well beyond the scales, like strength, bone, balance, blood sugar and independence as we age. But I want to be careful what I claim. None of the studies above show that eating enough protein or strength training stops weight coming back after you stop the medication. They are still good for you. They just aren't a guarantee.

What about the new weight-loss pills?

In May 2026, Nature Medicine published a trial called ATTAIN-MAINTAIN. People who had lost weight on tirzepatide (205 people) or semaglutide (171 people) were randomly assigned to take the pill orforglipron or placebo for a year. Those on the pill kept more of their weight loss than those on placebo, though not all of it [4].

Two caveats are worth knowing. The trial was sponsored by the pill's manufacturer, and it compared the pill with placebo, not with simply staying on the injection [4, 10]. So it tells us the pill held onto more weight than nothing, not that it beats continuing treatment. NICE is still assessing these medicines for the NHS (expected 27 January 2027).

So what does this mean in real life?

If you’re taking one of these medications, I’d think of stopping as something to plan for, not something you just do one day and hope for the best. Talk to the person who prescribes your medication about what stopping would look like, what follow-up you would have, and what support is available. Decisions about stopping, tapering or switching belong with them, not with a blog post, including this one.

It's also worth expecting that appetite may change, and not reading that as failure. If your appetite comes back, that is biology doing what biology does, not a lack of willpower.

Try to measure more than the scales. Strength, energy, sleep, blood pressure, whether you can carry the shopping up the stairs. These matter whatever the number does.

And if thoughts about food or weight are taking over your life, please tell your GP. Support is available and you don't need to manage it alone.

The honest summary is that these medications seem to work while you take them, and that stopping is a decision worth making deliberately, with a plan. The BMJ authors themselves urge caution about short-term use without a wider approach to weight management [1].

Health isn't built in grand gestures. It's built in ordinary days.

This is part of a short series looking honestly at what the research says about weight-loss medications, the good, the uncertain and the bits nobody tells you.

What are you wondering about? I'd love to hear. Click here to send me a message.

References

West S, et al. Weight regain after cessation of medication for weight management: systematic review and meta-analysis. BMJ 2026;392:e085304. doi:10.1136/bmj-2025-085304. https://pubmed.ncbi.nlm.nih.gov/41500720/
Aronne LJ, Sattar N, Horn DB, et al. Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: the SURMOUNT-4 randomized clinical trial. JAMA 2024;331(1):38-48. doi:10.1001/jama.2023.24945 https://pubmed.ncbi.nlm.nih.gov/38078870/
Wilding JPH, Batterham RL, Davies M, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes Obes Metab 2022;24(8):1553-1564. doi:10.1111/dom.14725 https://pubmed.ncbi.nlm.nih.gov/35441470/
Aronne LJ, et al. Orforglipron for maintenance of body weight reduction: the double-blind, randomized phase 3b ATTAIN-MAINTAIN trial. Nature Medicine 2026 (published 12 May 2026). https://www.nature.com/articles/s41591-026-04386-7
Look M, Dunn JP, et al. Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study of adults with obesity or overweight. Diabetes Obes Metab 2025. doi:10.1111/dom.16275. https://pmc.ncbi.nlm.nih.gov/articles/PMC11965027/
Arnaut T, et al. Retrospective assessment of food noise changes after initiation of injectable semaglutide for weight management in the USA: the INFORM survey. https://pubmed.ncbi.nlm.nih.gov/42217114/
Choi W, et al. Single-participant study of food noise and nucleus accumbens activity on tirzepatide. Nature Medicine, November 2025. https://pubmed.ncbi.nlm.nih.gov/41249493/
University of Oxford news release. New study finds that stopping weight-loss drugs is linked to faster regain than ending diet programmes. 8 January 2026. https://ox.ac.uk/news/2026-01-08-new-study-finds-stopping-weight-loss-drugs-linked-faster-regain-ending-diet
NIHR ARC Oxford and Thames Valley. New research shows people regain weight faster after stopping weight-loss drugs than after ending diet and exercise programmes. https://www.arc-oxtv.nihr.ac.uk/news/weight-loss-drug-regain-research
British Heart Foundation. Weight-loss pills: can orforglipron preserve weight loss after Mounjaro? https://www.bhf.org.uk/informationsupport/heart-matters-magazine/news/behind-the-headlines/weight-loss-pills-orforglipron